CURE's Top Stories: February 2020

News
Video

Here are the top five CURE® stories for February 2020.

Here are the top five CURE® stories for February 2020.

5. “I Never Met Frederic Mohs”

In this reader-submitted story, a skin cancer survivor shares his experience with squamous and basal cell carcinoma — and the healthy-tissue-sparing surgery that removed those cancerous cells and has him back to living life to the fullest.

4. Understanding Prevention For Hereditary Cancer

In honor of National Cancer Prevention Month, we take an in-depth look at how knowledge is power when it comes to hereditary cancers, in this piece.

3. Just Remember Not to Stop

Here, a cancer survivor laments not getting more done until she realizes that she just moves slower, and that's OK. As long as you don't stop.

2. New Blood Test Could Detect Cancer Cells

In this story, we look at a new study that supports the use of a blood test to detect clusters of cancer cells in the blood of asymptomatic individuals, potentially giving patients a non-invasive screening and testing method.

1. Finding Purpose After Five Different Cancers

In this episode of the “CURE Talks Cancer” podcast, we spoke with Lainie Jones, who found her purpose in helping others after being diagnosed with five separate primary cancers before the age of 35 because of Li-Fraumeni syndrome, a rare genetic condition that predisposes her to develop the disease.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE